Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio.
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy. giorgio.bogani@istitutotumori.mi.it.
Giorgio
http://orcid.org/0000-0001-8373-8569
G
Bogani
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Valentina
V
Chiappa
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Antonino
A
Ditto
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Fabio
http://orcid.org/0000-0002-4863-1747
F
Martinelli
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Mauro
M
Signorelli
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Domenica
D
Lorusso
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Francesco
F
Raspagliesi
D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000601:surgery*; D000069577:Morcellation / Q000009:adverse effects; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration; D014594:Uterine Neoplasms / Q000601:surgery*